Characteristic roadmap of linker governs the rational design of PROTACs
Proteolysis targeting chimera (PROTAC) technology represents a groundbreaking development in drug discovery, leveraging the ubiquitin‒proteasome system to specifically degrade proteins responsible for the disease. PROTAC is characterized by its unique heterobifunctional structure, which comprises tw...
Saved in:
Main Authors: | Yawen Dong (Author), Tingting Ma (Author), Ting Xu (Author), Zhangyan Feng (Author), Yonggui Li (Author), Lingling Song (Author), Xiaojun Yao (Author), Charles R. Ashby, Jr (Author), Ge-Fei Hao (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel approaches for the rational design of PROTAC linkers
by: Almaz Zagidullin, et al.
Published: (2020) -
Current strategies for the design of PROTAC linkers: a critical review
by: Robert I. Troup, et al.
Published: (2020) -
Estrogen Receptor-α Targeting: PROTACs, SNIPERs, Peptide-PROTACs, Antibody Conjugated PROTACs and SNIPERs
by: Arvind Negi, et al.
Published: (2022) -
Non-small molecule PROTACs (NSM-PROTACs): Protein degradation kaleidoscope
by: Sinan Ma, et al.
Published: (2022) -
Antibody-drug conjugates: Recent advances in linker chemistry
by: Zheng Su, et al.
Published: (2021)